
Ceftroxiv-TZ 1.125 Injection
Marketer
Mediva Lifecare
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Ceftroxiv-TZ 1.125 Injection
Ceftroxiv-TZ 1.125 Injection, a dual-action medication, combats a range of bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must be strictly under a doctor's guidance; adhere to the prescribed schedule without interruption. Complete the full treatment course, regardless of symptom improvement, as premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; escalating side effects warrant immediate medical attention. Allergic reactions (skin rashes, itching, edema, respiratory distress) require prompt medical help. Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to the risk of increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and sufficient hydration are crucial for optimal recovery. Your doctor may order lab tests to monitor treatment response.
Primary Ingredients of Ceftroxiv-TZ 1.125 Injection
No text provided. Please provide the text you would like me to rephrase.
Uses of Ceftroxiv-TZ 1.125 Injection
Infections caused by bacteria
Major Benefits of Ceftroxiv-TZ 1.125 Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.
Common Side effects of Ceftroxiv-TZ 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ceftroxiv-TZ 1.125 Injection:
This medication will be administered by your physician or their registered nurse; self-medication is strictly prohibited.
How Ceftroxiv-TZ 1.125 Injection works:
Ceftroxiv-TZ 1.125 Injection unites Ceftriaxone, a crucial antibiotic, with Tazobactum, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Tazobactum complements this by countering bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Ceftroxiv-TZ 1.125 Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Ceftroxiv-TZ 1.125 Injection is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; clinical data from human trials, however, remain scarce.
Breast feedingCAUTION
The administration of Ceftroxiv-TZ 1.125 Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Ceftroxiv-TZ 1.125 Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Ceftroxiv-TZ 1.125 Injection administration to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Individuals with significant hepatic impairment should receive Ceftroxiv-TZ 1.125 Injection cautiously, with potential dosage modification. Consult a physician for guidance. Dosage alteration for Ceftroxiv-TZ 1.125 Injection is unnecessary for those with mild or moderate liver dysfunction.
What if you forget to take Ceftroxiv-TZ 1.125 Injection :
Omitting a Ceftroxiv-TZ 1.125 Injection dose necessitates contacting your physician.
Facts to Know About Ceftroxiv-TZ 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
